A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | NEJM
Vaccines | Free Full-Text | Is Booster Dose Strategy Sufficient for Omicron Variant of SARS-CoV-2?
Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years | Nature Medicine
Covid booster vaccines effective against severe illness from omicron, CDC says
What We Know About Getting a Second Booster Shot of COVID-19 Vaccines | The Scientist Magazine®
What We Know About Getting a Second Booster Shot of COVID-19 Vaccines | The Scientist Magazine®
COVID-19 vaccine breakthrough infections | Science
What We Know About Getting a Second Booster Shot of COVID-19 Vaccines | The Scientist Magazine®
Covid booster doses will be offered to over-40s - BBC News
Vaccines | Free Full-Text | The Four Ws of the Fourth Dose COVID-19 Vaccines: Why, Who, When and What
Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study | The BMJ
How Long Does COVID Immunity Last After a Booster Shot?
I'm a physician over age 50 and I'm not getting my second COVID booster yet. Here's why. | Opinion
COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study - The Lancet Infectious Diseases
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials - The Lancet
Why do Covid boosters offer greater protection against Omicron?
Safety Monitoring of COVID-19 mRNA Vaccine Second Booster Doses Among Adults Aged ≥50 Years — United States, March 29, 2022–July 10, 2022 | MMWR
Boosting immunity to COVID-19 vaccines | Nature Medicine
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK - The Lancet
Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years | Nature Medicine
Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested test-negative design - The Lancet Infectious Diseases
Frontiers | Association Between Risk Perception and Acceptance for a Booster Dose of COVID-19 Vaccine to Children Among Child Caregivers in China
What We Know So Far About Waning Vaccine Effectiveness - The New York Times
Pfizer says its COVID shots are 73 percent effective in children under 5 | PBS NewsHour
